Inhibition of the IL-17A axis Protects against Immune-related Adverse Events while Supporting Checkpoint Inhibitor Anti-tumor Efficacy
Melissa G. Lechner(University of California, Los Angeles), Marueen Su
Cited by 0
Related Papers
Inhibition of the IL-17A axis Protects against Immune-related Adverse Events while Supporting Checkpoint Inhibitor Anti-tumor Efficacy
|bioRxiv (Cold Spring Harbor Laboratory)|2022|2
Polyfunctional IL-21 <sup>+</sup> IFNγ <sup>+</sup> T follicular helper cells contribute to checkpoint inhibitor diabetes mellitus and can be targeted by JAK inhibitor therapy
|bioRxiv (Cold Spring Harbor Laboratory)|2024|1